Newsfeeds - Spark Newswire

3 minute read

TFF Pharma Reports Safety, Pharmacokinetic Data From Phase 1 Study Of Niclosamide Inhalation Powder: Was Well Tolerated With No Severe Adverse Events

Today, 6:44 AM

Niclosamide Inhalation Powder Well Tolerated with No Serious Adverse Events Across All Subject Cohorts Current Data Suggests Niclosamide Inhalation Powder is a Promising Antiviral Treatment to Combat COVID-19 FORT

TFFP

2 minute read

Earnings

Looking Into TFF Pharmaceuticals’s Return On Capital Employed

By Benzinga Insights

Today, 6:44 AM

Benzinga Pro data, TFF Pharmaceuticals (NASDAQ:TFFP) reported Q4 sales of $12.00 thousand. Earnings fell to a loss of $10.05 million, resulting in a 15.8% decrease from last quarter.

TFFP

3 minute read

The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO

By Shanthi Rexaline

Today, 6:44 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ANTX

5 minute read

Earnings Scheduled For March 24, 2022

By Benzinga Insights

Today, 6:44 AM

Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter.

ADMA

1 minute read

Earnings

Earnings Outlook For TFF Pharmaceuticals

By Benzinga Insights

Today, 6:44 AM

TFF Pharmaceuticals (NASDAQ:TFFP) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts estimate that TFF Pharmaceuticals will report an earnings per share (EPS) of $-0.27.

TFFP

3 minute read

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings

By Shanthi Rexaline

Today, 6:44 AM

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment during the week.

APLT

3 minute read

TFF Pharmaceuticals Enters Into CRADA With The U.S. Army And The Geneva Foundation To Develop Dry Powder Needle-free Medical Countermeasures; Terms Not Disclosed

By Benzinga Newsdesk

Today, 6:44 AM

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technologyTFF Pharmaceuticals, Inc. (NASDAQ:TFFP

TFFP

1 minute read

TFF Pharma’s Inhaled Niclosamide Shows Potent Activity Against Omicron Variant

By Vandana Singh

Today, 6:44 AM

Preclinical studies show that TFF Pharmaceuticals Inc's (NASDAQ: TFFP) inhaled niclosamide product candidate

TFFP

7 minute read

Trading Ideas

Recently Revealed Pfizer Collaboration Might Just Be What The Doctor Ordered For TFF Pharmaceuticals

By Benzinga Contributor

Today, 6:44 AM

By StoryTrading Pfizer collaboration just revealed in presentation update - no PR issued yet! – Several near-term catalysts possible, including further partnerships with big pharma – Sentiment: CEO’s credibility hit from under-delivering now turning around

PFE

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 6:44 AM

Gainers

ALLK